Serum and serum substitutes: virus safety by inactivation or removal.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H Willkommen.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Screening blood donations for antibodies against hepatitis C virus (HCV) greatly reduces the risk of transmitting HCV by transfusions. However, despite such screening programs, plasma pools still contain a high percentage of HCV ribonucleic acid as determined by polymerase chain reaction. This result would not be alarming if the procedures for producing blood products included steps to inactivate or remove HCV. Although this appeared to be the case for all blood products, such as coagulation factors and most immunoglobulins, which are subjected to an inactivation step, the effectiveness of the cold ethanol fractionation process still needed to be determined. In validation experiments using bovine viral diarrhea virus as a model virus for HCV, we demonstrated that the Cohn-Oncley cold ethanol fractionation process neither inactivated nor removed this virus sufficiently. Our observations may help to explain how HCV was transmitted to a number of recipients of intravenous immunoglobulin.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A significant dependence between different ionic strength and pH value of virus suspension on one hand and the haemagglutinin (HA) content as determined by single-radial-immunodiffusion (SRD) test on the other hand was observed after cleavage of influenza virus recombinant NIB-6 (H1N1) with sodium lauroyl sarcosinate (SLS). In contrast, no such relationship was found when the HA Of NIB-4 (H3N2) recombinant strain was determined.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.